Imaging

The Technology Transfer Office Aquitaine Science Transfert (AST) aims to accelerate the dissemination of innovations on the market. AST supports innovative concepts from the researcher’s invention until proof-of-concept has been established. For a project of our portfolio, we were looking for a partner to evaluate the antiviral activity of a patented compound on infection and replication of different virus families. We had efficient and productive interactions with Dr Franck Gallardo and his team throughout the project to design the study, plan the execution and discuss about the results. I would highly recommend Neovirtech for antiviral drug evaluation.

We are closely working with NeoVirTech as our partner on a wide range of imaging technologies. Together, we bring a comprehensive imaging platform ranging from the basic fluorescence, through the high content spinning-disk to lightsheet microscopy. That way, we can visualize 2D and 3D samples like infected spheroids. We also work together in image processing to design automatic and custom-made algorithms for quantification. NeoVirTech high-level expertise in virology combined with our know-how have led to reliable results allowing our clients to obtain unique endpoints.

As Technology Transfer Accelerator Office, Sayens use to collaborate with technological companies having specific skills needed for our development programs. Thanks to its unique technology and comprehensive platform, NeoVirTech revealed been a highly competent company in antiviral drug evaluation for one of our program. I also really appreciate working with Dr. Franck Gallardo and his team, which were available at every step of the project, brought a strong expertise and a valuable follow up of the experiments.

A strong partnership has been established between NeoVirtech and our lab (ICMUB, Dijon) in the frame of an innovative research program, supported by SATT SAYENS. Neovirtech’s team, headed by Dr. Franck Gallardo, was a key partner for project success, by providing a very strong expertise and high quality-service in the field of antiviral molecules development. A very appreciate added value, highlighting the benefit of public/private partnership for speeding up development program.

The Technology Transfer Office Aquitaine Science Transfert (AST) aims to accelerate the dissemination of innovations on the market. AST supports innovative concepts from the researcher’s invention until proof-of-concept has been established. For a project of our portfolio, we were looking for a partner to evaluate the antiviral activity of a patented compound on infection and replication of different virus families. We had efficient and productive interactions with Dr Franck Gallardo and his team throughout the project to design the study, plan the execution and discuss about the results. I would highly recommend Neovirtech for antiviral drug evaluation.